Evrofarma SA (ATH:EVROF)
Greece
· Delayed Price · Currency is EUR 1.855
-0.005 (-0.27%)
Apr 3, 2025, 1:36 PM EET
Evrofarma Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Revenue | 46.84 | 48.76 | 45.38 | 36.7 | 33.91 | 33.48 | Upgrade
|
| Revenue Growth (YoY) | -4.88% | 7.45% | 23.66% | 8.23% | 1.28% | 2.90% | Upgrade
|
| Cost of Revenue | 39.78 | 41.7 | 39.59 | 32.86 | 28.92 | 27.43 | Upgrade
|
| Gross Profit | 7.06 | 7.06 | 5.8 | 3.84 | 4.99 | 6.06 | Upgrade
|
| Selling, General & Admin | 4.73 | 4.64 | 4.69 | 4.73 | 4.65 | 4.7 | Upgrade
|
| Other Operating Expenses | -1.08 | -1.24 | -1.15 | -1.12 | -1.14 | -0.83 | Upgrade
|
| Operating Expenses | 3.65 | 3.4 | 3.54 | 3.61 | 3.51 | 3.87 | Upgrade
|
| Operating Income | 3.42 | 3.66 | 2.26 | 0.23 | 1.48 | 2.19 | Upgrade
|
| Interest Expense | -1.31 | -1.32 | -0.84 | -0.78 | -0.82 | -0.74 | Upgrade
|
| Earnings From Equity Investments | 0.04 | 0.06 | 0.02 | 0.03 | 0.01 | -0 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.07 | -0.07 | -0.07 | -0.01 | 0.21 | -0.02 | Upgrade
|
| EBT Excluding Unusual Items | 2.07 | 2.32 | 1.36 | -0.54 | 0.88 | 1.42 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0 | -0 | - | -0.02 | -0.03 | 0.04 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | 0 | 0.04 | 0 | Upgrade
|
| Asset Writedown | 0.69 | 0.39 | 0.16 | 0.3 | 0.29 | 0.4 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -1.54 | Upgrade
|
| Pretax Income | 2.76 | 2.71 | 1.52 | -0.26 | 1.17 | 0.33 | Upgrade
|
| Income Tax Expense | 0.57 | 0.51 | 0.1 | 0.1 | 0.12 | 0.17 | Upgrade
|
| Net Income | 2.19 | 2.2 | 1.42 | -0.36 | 1.06 | 0.16 | Upgrade
|
| Net Income to Common | 2.19 | 2.2 | 1.42 | -0.36 | 1.06 | 0.16 | Upgrade
|
| Net Income Growth | -23.45% | 55.18% | - | - | 574.52% | -83.96% | Upgrade
|
| Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade
|
| Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade
|
| Shares Change (YoY) | 0.05% | 0.05% | -0.02% | - | - | - | Upgrade
|
| EPS (Basic) | 0.16 | 0.16 | 0.10 | -0.03 | 0.08 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.16 | 0.16 | 0.10 | -0.03 | 0.08 | 0.01 | Upgrade
|
| EPS Growth | -23.49% | 55.11% | - | - | 574.53% | -83.96% | Upgrade
|
| Free Cash Flow | 2.45 | 0.53 | 0.6 | -4.15 | 0.55 | 0.9 | Upgrade
|
| Free Cash Flow Per Share | 0.18 | 0.04 | 0.04 | -0.30 | 0.04 | 0.07 | Upgrade
|
| Dividend Per Share | 0.050 | 0.050 | - | - | - | - | Upgrade
|
| Gross Margin | 15.08% | 14.48% | 12.77% | 10.46% | 14.70% | 18.09% | Upgrade
|
| Operating Margin | 7.29% | 7.50% | 4.97% | 0.63% | 4.35% | 6.53% | Upgrade
|
| Profit Margin | 4.67% | 4.52% | 3.13% | -0.97% | 3.12% | 0.47% | Upgrade
|
| Free Cash Flow Margin | 5.23% | 1.09% | 1.32% | -11.31% | 1.63% | 2.70% | Upgrade
|
| EBITDA | 5.1 | 5.31 | 3.75 | 1.63 | 2.82 | 3.57 | Upgrade
|
| EBITDA Margin | 10.90% | 10.89% | 8.26% | 4.45% | 8.31% | 10.65% | Upgrade
|
| D&A For EBITDA | 1.69 | 1.66 | 1.49 | 1.4 | 1.34 | 1.38 | Upgrade
|
| EBIT | 3.42 | 3.66 | 2.26 | 0.23 | 1.48 | 2.19 | Upgrade
|
| EBIT Margin | 7.29% | 7.50% | 4.97% | 0.63% | 4.35% | 6.53% | Upgrade
|
| Effective Tax Rate | 20.70% | 18.66% | 6.77% | - | 9.80% | 51.84% | Upgrade
|
| Advertising Expenses | - | 0.17 | 0.16 | 0.12 | 0.12 | 0.13 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.